Molecular Karyotyping-Prenatal-Illumina 720K
Definition
This SNP microarray based method can detect, beyond the large aneuploidies and unbalanced rearrangements above 5-10 Mb that classic karyotyping can see, microdeletions/microduplications, triploidy, uniparental isodisomy, and low-level mosaicism. ACOG and SMFM recommend that chromosomal microarray analysis (CMA) replace fetal karyotyping in cases with structural anomalies or fetal death; because it can be performed on uncultured DNA samples, the turnaround time is shorter than karyotyping.
Note: Pricing includes a maternal contamination test along with the material; the sample must be sent as EDTA blood. The test may not yield a result on products of conception; in this case the test is still billed.
Gene/region examined
*
Method
SNP Array
Accepted sample types
Cord blood (EDTA), Amniocentesis, CVS
Inheritance
Not applicable, this is a diagnostic method (it screens for inherited/de novo copy number changes in the fetal genome from a prenatal sample).